LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹-47 Cr | ₹-21 Cr |
What is the latest Net Current Assets ratio of LYKA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹-47 Cr |
| Mar2021 | ₹-21 Cr |
How is Net Current Assets of LYKA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 61.49 | |
| Mar2024 | ₹13 Cr | 10.99 | |
| Mar2023 | ₹12 Cr | Positive | |
| Mar2022 | ₹-47 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Net Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹269.1 Cr | 4.1% | -0.7% | -51.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 4.1% |
-0.7% |
-51.8% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses